M

Michael G. Martin

University of Tennessee Health Science Center

ORCID: 0000-0002-9310-724X

147 papers and 3.1k citations.

PubIndex Score92Top 8%How it's scored

🌟#6 Current Senior Leader in Banking, Crisis Management, COVID-19 Impact

147Publications

3.1kTotal Citations

#6in Banking, Crisis Management, COVID-19 Impact

First senior author: 2013

Top publicationsby citations

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret O’Donnell, Ndiya Ogba, Marcos de Lima et al.|Journal of the National Comprehensive Cancer Network|2017

Cited by 655

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017

William G. Wierda, Hema Sundar, Andrew D. Zelenetz et al.|Journal of the National Comprehensive Cancer Network|2017

Cited by 62

Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.

George Yaghmour, Michael G. Martin, Manjari Pandey et al.|PubMed|2016

Cited by 29

Role of genomic instability in immunotherapy with checkpoint inhibitors.

George Yaghmour, Michael G. Martin, Manjari Pandey et al.|Journal of Clinical Oncology|2016

Cited by 16

Impact of provider volume on outcomes of patients with Hodgkin lymphoma.

Catherine G. Ireland, Michael G. Martin, Muhammad M. Mirza et al.|Journal of Clinical Oncology|2016

Cited by 0

Indexing the rest of 147 publications…